- Home
- MAMA vs CRVS Comparison
MAMA vs CRVS Comparison
Compare MAMA & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- CRVS
- Stock Information
- Founded
- MAMA 2010
- CRVS 2014
- Country
- MAMA United States
- CRVS United States
- Employees
- MAMA N/A
- CRVS N/A
- Industry
- MAMA Specialty Foods
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- MAMA Consumer Staples
- CRVS Health Care
- Exchange
- MAMA Nasdaq
- CRVS Nasdaq
- Market Cap
- MAMA 323.1M
- CRVS 305.4M
- IPO Year
- MAMA N/A
- CRVS 2016
- Fundamental
- Price
- MAMA $7.98
- CRVS $5.75
- Analyst Decision
- MAMA Strong Buy
- CRVS Strong Buy
- Analyst Count
- MAMA 3
- CRVS 4
- Target Price
- MAMA $10.33
- CRVS $15.00
- AVG Volume (30 Days)
- MAMA 154.7K
- CRVS 518.7K
- Earning Date
- MAMA 09-08-2025
- CRVS 08-07-2025
- Dividend Yield
- MAMA N/A
- CRVS N/A
- EPS Growth
- MAMA N/A
- CRVS N/A
- EPS
- MAMA 0.11
- CRVS N/A
- Revenue
- MAMA $128,745,000.00
- CRVS N/A
- Revenue This Year
- MAMA $17.24
- CRVS N/A
- Revenue Next Year
- MAMA $9.95
- CRVS N/A
- P/E Ratio
- MAMA $72.57
- CRVS N/A
- Revenue Growth
- MAMA 17.04
- CRVS N/A
- 52 Week Low
- MAMA $5.50
- CRVS $2.54
- 52 Week High
- MAMA $9.98
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- MAMA 41.43
- CRVS 65.10
- Support Level
- MAMA $8.37
- CRVS $5.28
- Resistance Level
- MAMA $8.74
- CRVS $5.64
- Average True Range (ATR)
- MAMA 0.31
- CRVS 0.30
- MACD
- MAMA -0.00
- CRVS 0.03
- Stochastic Oscillator
- MAMA 10.11
- CRVS 77.70
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).